CompoAtlas

FASÉOLAMINE

Food supplement declared in France, declaration No 2016-10-837, decision dated 21 October 2016

FASÉOLAMINE (DRASANVI) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
DRASANVI
Food business operator placing the product on the market
DRASANVI
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Capsule
Daily dose
2 capsule
Directions for use
Prendre 2 capsules avant de chaque repas riche en hydrates de carbone.Ne pas prendre plus de 4 caps.
Not recommended for (according to the manufacturer)
Enfants (moins de 12 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Minceur / Brûleur

Declaration 157866, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Phaseolus vulgaris L.GraineExtrait sec aqueux1,000 mg

Additives

E464, E460, E470b, E551

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : DRASANVI

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line